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Experience of single pre-close device for percutaneous abdominal aortic
aneurysm repair
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Etsuo Tsuchikane1, Tetsuo Matsubara1, Takahiko Suzuki1
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Background: Totally percutaneous endovascular abdominal aortic aneurysm repair
by using multiple pre-close devises for large arteriotomy closure has been previously
described. However they were needed more than 2 devices. Here we report the results
of a percutaneous technique using single pre-close devise.
Methods: A total of 60 sites in 30 consecutive patients (29 male ; mean age 74.17.1
years )with endovascular stent-graft treatment from May 2013 through March 2014
were required for large-bore sheath insertion. In 58 of 60 sites we performed percu-
taneous suture. Stent-graft devices were introduced through 20Fr ( n¼2 ), 18Fr ( n¼20
), 16Fr ( n¼24 ), 14Fr ( n¼2 ), 12Fr ( n¼10 ) sheaths. Two sites we chose cut-down
suture. Because one femoral site was implanted stent and one had severe calciﬁcation.
After deployment single pre-close device ( Perclose ProGlide ), large-bore sheaths
were inserted. After treatment hemostasis was achieved using pre-close sutures placed
before procedure. If bleeding or oozing persisted manual compression was performed.
All femoral site were followed physical examination, ankle brachial pressure index
(ABI) and computed tomography angiogram (CTA).
Results: We used multiple perclose devices in two sites, because of failure in pre-
close suture. Both major arterial complication requiring vascular surgical repair and
minor arterial complication like subcutaneous hematoma detected CTA did not
occurred. Mean manual compression time is 6.8 minutes. ABI was measured before
procedure ( 1.090.15 ) and afterward ( 1.080.17 ) and did not change signiﬁcantly
(P¼NS).
Conclusions: Percutaneous closure technique using single pre-close devices is useful
for hemostasis in endovascular stent-graft treatment for abdominal aortic aneurysm.
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Background: A novel stent method in treatment of ascending aortic and aortic arch
aneurysms was investigated.
Methods: A novel large (55mm x 120mm) nitinol stent was designed and it was
deployed in an ascending aorta and aortic arch in a patient-speciﬁc model. The edges
of the stent were ﬂared for better apposition in aortic aneurysm on both edges of the
stent. The stent was later embedded in the aortic wall, and subsequently after
embedding a tissue overgrowth of 1mm was modeled over the stent. Pressure load was
applied in the aneurysm model with and without the stent, and also after embedding
the stent in aortic wall. The wall stresses were studied in all the four scenarios by ﬁnite
element analysis (Abaqus).
Results: There was signiﬁcant reduction in wall stresses after stent deployment and
embedding as shown in the ﬁgure. The endovascular (sax-like) stent had the ability to
reduce aortic wall stresses signiﬁcantly when deployed. Stenting and embedding re-
duces the expansion of aortic regions at high stress, both at 100 and 180mmHg.
Subsequently the tissue overgrowth was modeled parametrically and the effect of
tissue overgrowth with 0.25 mm was studied. With tissue overgrowth of 0.25mm there
was signiﬁcant reduction in wall stresses. Also the stent was proximally placed below
the coronaries and distally extended to study its effects. There were no damaging
stresses on the aorta after ﬂaring of the stents.
Conclusions: There is a potential for a novel self expanding stent method in treatment
of ascending aorta and aortic arch aneurysms.B166 JACC Vol 64/11/Suppl B j September 13–17, 2TCT-572
A NEW CONCEPT OF STENT: THE MULTILAYER FLOW MODULATOR
STENT FOR THE TREATMENT OF THORACO ABDOMINAL AND
ABDOMINAL AORTIC ANEURYSMS.
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Background: Thoraco Abdominal Aortic Aneurysms (TAAA) and Abdominal Aortic
Aneurysms (AAA) are traditionally treated surgically, but more and more by inter-
ventional procedures (endografts, fenestrated, branched grafts, chimney techniques).
We used a new concept of stent, the Multilayer Stent Flow Modulator (M.F.M) to treat
these aneurysms (A) and try to avoid some major complications.
Methods: This selfexpandable M.F.M is a 3 D braided tube made of several inter-
connected layers without any covering. We will explain and demonstrate the key
principles of the stent leading to thrombosis, shrinkage of the A, eliminating the risk of
rupture. Moreover, this M.F.M preserves the collateral branches allowing the possi-
bility to cover any artery without compromising the ﬂow (renal, digestive arteries,
supra aortic vessels.)
Results: Based on recent published series: - Our personal Moroccan series, 10
TAAA, 8 AAA in very high risk pts. o Technical success: 100% o At 30 days no
neurological complication, branch patency 100% no death o During the follow up
3 deaths not device related. CT scan control at 1, 3, 6, 12, 18 months with calculation
of A. Diameters and Volumes. o Collateral branches patency: 100%. o Progressive
thrombosis and shrinkage of the aneurysmal sac depending on the size of the col-
laterals. o Signiﬁcant mean diameter reduction between baseline and 6 months:
17,25 mm reduction for the transversal diameter 13,83 mm for the antero posterior
diameter in the TAAA group. o Overtime the ratio thrombus volume / Total Volume
is increasing and the ratio Residual Flow Volume / Total Volume is decreasing.
- French registry: 23 pts, 30 day mortality: 0%. At 1 year: branch patency 97%,
neurological complication 0%. - Other series: 48 pts. The problems of the thrombosis,
shrinkage and volume reduction of the aneurismal sac will be discussed. The com-
plications rates with M.F.M appear lower in comparison with current endovascular
techniques, and with surgery.
Conclusions: The M.F.M represents an alternative to current devices to treat TAAA
and AAA. The ﬁrst results are promising, it is a safe procedure with a low
complication rate. No neurological complications are observed. A larger study is
ongoing.
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Triple-Antimicrobial-Bonded Graft for Preventing Perioperative Aortic
Infection
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Background: Several graft manufacturers have proposed using antibiotic-bonded
grafts to prevent or treat graft infection. We tested our novel triple-antimicrobial-
bonded graft’s ability to prevent infection for 8 weeks after implantation and used
chemical assays to assess the graft’s potential to resist infection over this extended
time period.
Methods: We added 9 Sinclair miniature pigs to our previous pilot cohort (n¼6). In
the current phase, all pigs received a 6-mm vascular Dacron graft in the infrarenal
portion of the abdominal aorta. Five pigs received grafts chemically bonded with a 60-
mg/mL solution of rifampin, minocycline, and chlorhexidine; the other 4 pigs received
unbonded grafts. Before implantation, the 5 bonded grafts and 3 of the unbonded
grafts were immersed for 15 min in a 2-mL solution containing 1 to 2107 CFU/mL
Staphylococcus aureus (ATCC 29213); the 4th unbonded graft served as a control.
After 8 weeks of observation, plasma levels of rifampin were measured by quantitative
high-performance liquid chromatography (HPLC) assay.
Results: All S. aureus–treated bonded grafts (n¼7) showed no bacterial growth on
explantation. The unbonded, untreated grafts (n¼3) showed low level bacterial growth
(1.8103, 7.27103, and 1.2103 CFU/graft); S. cohnii ssp urealyticus, but not S.
aureus, was isolated, suggesting accidental direct perioperative contamination. Two
pigs that of the group received S. aureus–treated (n¼5), unbonded grafts were
euthanized because of severe infection with S. aureus (bacterial counts: 6.25106 and
1.38107 CFU/graft).
Conclusions: Our results suggest that triple-bonded aortic grafts prevented periop-
erative aortic graft infection for 8 weeks in a porcine model. Plasma levels of rifampin
were sufﬁcient to prevent or eradicate infection during that period and possibly for
another 8 weeks thereafter. After this graft’s protective effects and safety have been
further assessed, its use may be recommended for in situ replacement of infected grafts
and possibly for routine primary cases, especially in patients who are immunocom-
promised, have hostile abdomen, or undergo redo procedures.014 j TCT Abstracts/Aortic Endograft Intervention (not aortic stenosis)
